|
Young Minority Scientists in the Field of Cancer
|
5R13CA040577-32
|
$69,443
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Wisconsin NCI Community Oncology Research Program (WiNCORP)
|
5UG1CA189956-05
|
$2,080,158
|
|
ONITILO, ADEDAYO
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-05
|
$3,106,081
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Viruses and Cancer
|
5T32CA060395-22
|
$156,724
|
|
MEYERS, CRAIG
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Viral priming and targeting NK cells against solid tumor malignancies
|
5R35CA197292-04
|
$796,220
|
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program
|
5UG1CA189869-05
|
$1,196,666
|
|
GEYER, CHARLES
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-03
|
$386,051
|
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
5R01CA217625-02
|
$635,068
|
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UW Radiological Sciences Training Program
|
5T32CA009206-40
|
$499,580
|
|
HALL, TIMOTHY
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utility of RAS mimetics to block oncogenic signaling in colorectal cancer
|
1R21CA227963-01
|
$221,198
|
|
REDDY, E
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
5R01CA210259-02
|
$667,691
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
|
5U01CA199216-04
|
$623,508
|
|
JACKSON, PETER
|
STANFORD UNIVERSITY
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-19
|
$302,547
|
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-12
|
$254,589
|
$25,459
|
SCARDINO, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,932,712
|
$96,635
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
|
5R01CA190642-04
|
$436,922
|
|
SCALTRITI, MAURIZIO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
University of Washington/Fred Hutch Center for AIDS Research
|
2P30AI027757-31
|
$508,801
|
|
BAETEN, JARED
|
UNIVERSITY OF WASHINGTON
|
|
University of Rochester-NCORP Research Base
|
5UG1CA189961-05
|
$4,001,073
|
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-14
|
$2,246,011
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding the role of IDH in malignant gliomas
|
2R01CA154843-06A1
|
$384,750
|
|
MAHER, ELIZABETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
|
5R01CA208100-02
|
$483,284
|
|
CHEN, YU
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding the niche of minimal residual disease leukemia cells
|
2R01CA172896-06
|
$402,563
|
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Understanding Smokeless Tobacco and Electronic Cigarette Marketing
|
5R01CA141661-09
|
$559,091
|
|
LING, PAMELA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding How Breast Cancers Activate and Respond to the Systemic Environment
|
5R01CA166284-07
|
$148,621
|
|
MCALLISTER, SANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Understanding EGF receptor activation by growth factors and oncogenic mutations
|
5R01CA198164-04
|
$520,420
|
|
LEMMON, MARK
|
YALE UNIVERSITY
|
|
Uncovering roles of polyunsaturated fatty acids in pancreatic cancer etiology
|
1K99CA218892-01A1
|
$120,472
|
|
WU, LANG
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Ultrasensitive Quantitation of Circulating Tumor DNA
|
5R00CA187192-04
|
$249,000
|
|
NEWMAN, AARON
|
STANFORD UNIVERSITY
|
|
Ultrabright Theranostic SERRS Nanoparticles for Gastrointestinal Endoscopy
|
1R01CA222836-01A1
|
$716,909
|
|
KIRCHER, MORITZ
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
|
5U01CA198846-04
|
$459,169
|
|
NEL, ANDRE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-04
|
$352,275
|
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
UBAP2, A New Molecule in Pancreatic Cancer Progression
|
1R01CA220237-01A1
|
$331,688
|
|
MUKHERJEE, PRIYABRATA
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
UAB Cancer Research Experiences for Students
|
5R25CA076023-19
|
$302,400
|
|
WATERBOR, JOHN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
|
1R01CA217333-01A1
|
$593,022
|
|
NIJHAWAN, DEEPAK
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity
|
5R00CA204595-04
|
$249,000
|
|
SPRANGER, STEFANI
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
|
5F31CA196329-03
|
$31,856
|
|
NASCIMENTO, ALDO
|
UNIVERSITY OF VIRGINIA
|
|
Tumor suppressor role of the DREAM complex
|
5F31CA220800-02
|
$32,122
|
|
SCHADE, AMY
|
HARVARD MEDICAL SCHOOL
|
|
Tumor Suppressor Localization and Function at the Peroxisome
|
5R01CA143811-10
|
$356,625
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tumor Suppression by an African Specific Variant of p53
|
1F32CA220972-01A1
|
$59,038
|
|
BARNOUD, THIBAUT
|
WISTAR INSTITUTE
|
|
Tumor Plasticity
|
5R35CA220446-02
|
$1,140,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Tumor Cell Biology Training Program
|
5T32CA009056-42
|
$432,898
|
|
CROOKS, GAY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma
|
1R01CA214912-01A1
|
$629,914
|
|
DUBOIS, STEVEN
|
DANA-FARBER CANCER INST
|
|
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
|
5R01CA176624-05
|
$372,463
|
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-04
|
$561,808
|
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Translational Research Training in Cancer Etiology and Prevention
|
5T32CA186873-05
|
$130,769
|
|
YUAN, JIAN-MIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Translational Research in Oncology Training Program
|
5T32CA160001-08
|
$229,938
|
|
SAWYERS, CHARLES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology
|
5R33CA196458-03
|
$362,020
|
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
Total relevant funding to Testes for this search: $5,145,654
|